Company News, Financial News

J&J Consumer Health Spinoff Kenvue Begins IPO Roadshow

Expected to trade on the NYSE under KVUE.

Author Image

By: Christine Esposito

Editor-in-Chief

Johnson & Johnson’s Kenvue Inc.—the new standalone entity that represents J&J’s consumer health business—has launched the roadshow for the initial public offering (IPO) of 151,204,000 shares of its common stock. Kenvue’s portfolio includes Aveeno, Neutrogena, Johnsons, Dr. CI: Labo, Listerine and more iconic health brands like Band-Aid and Tylenol. J&J unveiled the new name for the unit in September 2022 previously reported by Happi. The healthcare giant announced the plan t...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters